Fig. 3

Individual anti-S1 Ig titres for COVID-19-negative patients. Data are shown as a function of the number of doses of vaccine received. Each grey line represents the change in an individual patient’s titre between the first and second serology assays (Ser₁ and Ser₂). The thick, black line was derived by non-parametric, locally estimated smoothing; it illustrates the trend for the group